{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T01:54:41Z","timestamp":1767837281180,"version":"3.49.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jaip.2025.09.025","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:08:38Z","timestamp":1758978518000},"page":"166-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Risk of Self-Harm and the Use of Leukotriene Receptor Antagonists and Inhaled Corticosteroids: A Population-Based Study"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2372-5181","authenticated-orcid":false,"given":"Boqing","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew S.C.","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth K.C.","family":"Man","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph F.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David P.J.","family":"Osborn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian C.K.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrienne Y.L.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lok Yin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yogini H.","family":"Jani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2320-0470","authenticated-orcid":false,"given":"Wallis C.Y.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2025.09.025_bib5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s40264-017-0607-1","article-title":"Neuropsychiatric events associated with leukotriene-modifying agents: a systematic review","volume":"41","author":"Law","year":"2018","journal-title":"Drug Saf"},{"key":"10.1016\/j.jaip.2025.09.025_bib9","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/pds.3758","article-title":"Exploring the possible association between montelukast and neuropsychiatric events among children with asthma: a matched nested case-control study","volume":"24","author":"Ali","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jaip.2025.09.025_bib10","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02467-2021","article-title":"Leukotriene-receptor antagonist and risk of neuropsychiatric events in children, adolescents, and young adults: a self-controlled case series","volume":"60","author":"Park","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.09.025_bib11","doi-asserted-by":"crossref","first-page":"4290","DOI":"10.1016\/j.jaip.2021.06.007","article-title":"Risk of neuropsychiatric diseases according to the use of a leukotriene receptor antagonist in middle-aged and older adults with asthma: a nationwide population-based study using health claims data in Korea","volume":"9","author":"Shim","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.09.025_bib12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40733-021-00070-4","article-title":"The role of leukotriene modifying agent treatment in neuropsychiatric events of elderly asthma patients: a nested case control study","volume":"7","author":"Kang","year":"2021","journal-title":"Asthma Res Pract"},{"key":"10.1016\/j.jaip.2025.09.025_bib13","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0079-2023","article-title":"Neuropsychiatric events associated with montelukast in patients with asthma: a systematic review","volume":"32","author":"Lo","year":"2023","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jaip.2025.09.025_bib14","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jaci.2012.04.035","article-title":"Risk of suicide attempt in asthmatic children and young adults prescribed leukotriene-modifying agents: a nested case-control study","volume":"130","author":"Schumock","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.09.025_bib15","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.13643","article-title":"Analysis of neuropsychiatric diagnoses after montelukast initiation","volume":"5","author":"Paljarvi","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jaip.2025.09.025_bib16","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jaip.2020.07.052","article-title":"Risk of psychiatric adverse events among montelukast users","volume":"9","author":"Sansing-Foster","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.09.025_bib17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1592\/phco.29.2.165","article-title":"Rate of suicide in patients taking montelukast","volume":"29","author":"Jick","year":"2009","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jaip.2025.09.025_bib18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2147\/DHPS.S23665","article-title":"Relationship between leukotriene-modifying agent prescriptions dispensed and rate of suicide deaths by county in the US","volume":"3","author":"Schumock","year":"2011","journal-title":"Drug Healthc Patient Saf"},{"key":"10.1016\/j.jaip.2025.09.025_bib19","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jpsychores.2014.08.017","article-title":"Asthma and self-harm: a population-based cohort study in Taiwan","volume":"77","author":"Chen","year":"2014","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.jaip.2025.09.025_bib20","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00228-006-0102-6","article-title":"Reported adverse drug reactions during the use of inhaled steroids in children with asthma in the Netherlands","volume":"62","author":"de Vries","year":"2006","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jaip.2025.09.025_bib21","doi-asserted-by":"crossref","DOI":"10.1080\/20018525.2022.2149920","article-title":"Adherence to inhaled corticosteroids in relation to quality of life and symptoms of anxiety and depression in asthma","volume":"10","author":"Renzi-Lomholt","year":"2023","journal-title":"Eur Clin Respir J"},{"key":"10.1016\/j.jaip.2025.09.025_bib22","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/j.1651-2227.2012.02805.x","article-title":"Preschool children with high adherence to inhaled corticosteroids for asthma do not show behavioural problems","volume":"101","author":"Quak","year":"2012","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jaip.2025.09.025_bib23","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.chest.2019.02.017","article-title":"Psychiatric collaborative care for patients with respiratory disease","volume":"155","author":"Yohannes","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2025.09.025_bib24","article-title":"Self controlled case series methods: an alternative to standard epidemiological study designs","volume":"354","author":"Petersen","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jaip.2025.09.025_bib25","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ije\/dyv098","article-title":"Data resource profile: Clinical Practice Research Datalink (CPRD)","volume":"44","author":"Herrett","year":"2015","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jaip.2025.09.025_bib26","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyz034","article-title":"Data resource profile: Clinical Practice Research Datalink (CPRD) Aurum","volume":"48","author":"Wolf","year":"2019","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jaip.2025.09.025_bib28","author":"Herrett"},{"key":"10.1016\/j.jaip.2025.09.025_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyx015","article-title":"Data resource profile: Hospital Episode Statistics Admitted Patient Care (HES APC)","volume":"46","author":"Herbert","year":"2017","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jaip.2025.09.025_bib30","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/pds.4747","article-title":"The accuracy of date of death recording in the Clinical Practice Research Datalink GOLD database in England compared with the Office for National Statistics death registrations","volume":"28","author":"Gallagher","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jaip.2025.09.025_bib32","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1136\/jech-2022-219200","article-title":"Completeness and representativeness of small area socioeconomic data linked with the UK Clinical Practice Research Datalink (CPRD)","volume":"76","author":"Mahadevan","year":"2022","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.jaip.2025.09.025_bib33","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/jamapsychiatry.2017.2183","article-title":"Association of risk of suicide attempts with methylphenidate treatment","volume":"74","author":"Man","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jaip.2025.09.025_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2023.115236","article-title":"Association between the mood stabilizing treatment of bipolar disorder and risk of suicide attempts: a self-controlled case series study","volume":"325","author":"Ng","year":"2023","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.jaip.2025.09.025_bib35","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S2352-4642(20)30100-0","article-title":"Association between methylphenidate treatment and risk of seizure: a population-based, self-controlled case-series study","volume":"4","author":"Man","year":"2020","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.jaip.2025.09.025_bib36","article-title":"Antidepressant use and risk of self-harm among people aged 40 years or older: a population-based cohort and self-controlled case series study","volume":"27","author":"Chai","year":"2022","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.jaip.2025.09.025_bib37","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-081627","article-title":"Use of gabapentinoid treatment and the risk of self-harm: population based self-controlled case series study","volume":"389","author":"Yuen","year":"2025","journal-title":"BMJ"},{"key":"10.1016\/j.jaip.2025.09.025_bib38","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1370\/afm.1377","article-title":"Pay-for-performance in the United Kingdom: impact of the quality and outcomes framework: a systematic review","volume":"10","author":"Gillam","year":"2012","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.jaip.2025.09.025_bib40","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12875-016-0479-y","article-title":"Suicide risk in primary care patients diagnosed with a personality disorder: a nested case control study","volume":"17","author":"Doyle","year":"2016","journal-title":"BMC Fam Pract"},{"key":"10.1016\/j.jaip.2025.09.025_bib41","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/bcp.12059","article-title":"Validation of suicide and self-harm records in the Clinical Practice Research Datalink","volume":"76","author":"Thomas","year":"2013","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaip.2025.09.025_bib42","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1016\/S2589-7500(19)30012-3","article-title":"A chronological map of 308 physical and mental health conditions from 4 million individuals in the English National Health Service","volume":"1","author":"Kuan","year":"2019","journal-title":"Lancet Digit Health"},{"key":"10.1016\/j.jaip.2025.09.025_bib43","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/jamia\/ocz105","article-title":"UK phenomics platform for developing and validating electronic health record phenotypes: CALIBER","volume":"26","author":"Denaxas","year":"2019","journal-title":"J Am Med Inform Assoc"},{"key":"10.1016\/j.jaip.2025.09.025_bib44","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1198\/jasa.2011.ap10108","article-title":"Self-controlled case series analysis with event-dependent observation periods","volume":"106","author":"Farrington","year":"2011","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.jaip.2025.09.025_bib45","author":"Mathieu"},{"key":"10.1016\/j.jaip.2025.09.025_bib46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/biostatistics\/kxn013","article-title":"Case series analysis for censored, perturbed, or curtailed post-event exposures","volume":"10","author":"Farrington","year":"2009","journal-title":"Biostatistics"},{"key":"10.1016\/j.jaip.2025.09.025_bib47","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/oxfordjournals.aje.a115853","article-title":"The case-crossover design: a method for studying transient effects on the risk of acute events","volume":"133","author":"Maclure","year":"1991","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jaip.2025.09.025_bib49","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/EDE.0b013e31821d09cd","article-title":"Future cases as present controls to adjust for exposure trend bias in case-only studies","volume":"22","author":"Wang","year":"2011","journal-title":"Epidemiology"},{"key":"10.1016\/j.jaip.2025.09.025_bib50","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jaci.2009.08.011","article-title":"Analysis of behavior-related adverse experiences in clinical trials of montelukast","volume":"124","author":"Philip","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.09.025_bib52","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1080\/02770903.2023.2293064","article-title":"Assessing the risk of intentional self-harm in montelukast users: an updated Sentinel System analysis using ICD-10 coding","volume":"61","author":"Apata","year":"2024","journal-title":"J Asthma"},{"key":"10.1016\/j.jaip.2025.09.025_bib53","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/jamapsychiatry.2019.4170","article-title":"All-cause and cause-specific mortality among people using extramedical opioids: a systematic review and meta-analysis","volume":"77","author":"Larney","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jaip.2025.09.025_bib54","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/pubmed\/fdx063","article-title":"Morbidity and mortality in opioid dependent patients after entering an opioid pharmacotherapy compared with a cohort of non-dependent controls","volume":"40","author":"Kelty","year":"2018","journal-title":"J Public Health (Oxf)"},{"key":"10.1016\/j.jaip.2025.09.025_bib55","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.4065\/81.10.1361","article-title":"Psychiatric adverse effects of corticosteroids","volume":"81","author":"Warrington","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaip.2025.09.025_bib56","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000501617","article-title":"Systemic and local corticosteroid use is associated with reduced executive cognition, and mood and anxiety disorders","volume":"110","author":"Savas","year":"2020","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.jaip.2025.09.025_bib57","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1651-2227.2008.00770.x","article-title":"Inhaled corticosteroids do not affect behaviour","volume":"97","author":"De Vries","year":"2008","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jaip.2025.09.025_bib59","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/pai.12000","article-title":"Prevalence of anxiety and depressive symptoms in adolescents with asthma: a meta-analysis and meta-regression","volume":"23","author":"Lu","year":"2012","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2025.09.025_bib60","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1183\/09031936.00011415","article-title":"The relationship between asthma and suicidal behaviours: a systematic literature review","volume":"46","author":"Barker","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.09.025_bib61","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12991-016-0122-2","article-title":"Suicidal ideation and suicide attempts among asthma","volume":"15","author":"Chung","year":"2016","journal-title":"Ann Gen Psychiatry"},{"key":"10.1016\/j.jaip.2025.09.025_bib62","first-page":"1615","article-title":"Anxiety and depression\u2014important psychological comorbidities of COPD","volume":"6","author":"Pumar","year":"2014","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.jaip.2025.09.025_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.764279","article-title":"Neuropsychiatric adverse events of montelukast: an analysis of real-world datasets and drug-gene interaction network","volume":"12","author":"Umetsu","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jaip.2025.09.025_bib65","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jpsychires.2023.05.066","article-title":"Definitions and incidence rates of self-harm and suicide attempts in Europe: a scoping review","volume":"164","author":"Jakobsen","year":"2023","journal-title":"J Psychiatr Res"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825009195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825009195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T09:48:37Z","timestamp":1767779317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219825009195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2213219825009195"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2025.09.025","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of Self-Harm and the Use of Leukotriene Receptor Antagonists and Inhaled Corticosteroids: A Population-Based Study","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2025.09.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}